Viewing StudyNCT06425302



Ignite Creation Date: 2024-06-16 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06425302
Status: RECRUITING
Last Update Posted: 2024-05-31
First Post: 2024-05-17

Brief Title: A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
Sponsor: Celgene
Organization: Celgene

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-08-03
Start Date Type: ESTIMATED
Primary Completion Date: 2026-11-23
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-11-27
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-17
First Submit QC Date: May 17 2024
Study First Post Date: 2024-05-22
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-22
Last Update Post Date: 2024-05-31
Last Update Post Date Type: ACTUAL